Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

James T. Casper MD
Professor
Department of Pediatrics
Division of Hematology/Oncology

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

CITIZENSHIP:  USA

EDUCATION:
1966 BA, University of Notre Dame, Notre Dame, IN
1970 MD, Medical College of Wisconsin (Formerly Marquette University School of Medicine), Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1970 - 1971 Intern, Milwaukee Children's Hospital, Milwaukee, WI WI
1971 - 1972 Resident, Milwaukee Children's Hospital , Milwaukee, WI
1972 - 1974 Fellowship, Immunology, Milwaukee Blood Center and Milwaukee Children's Hospital, Milwaukee, WI

MILITARY SERVICE:
1971 - 1972 First Lieutenant, Medical Corps, USAR
1972 - 1977 Captain, Medical Corps, USAR

FACULTY APPOINTMENTS:
1970 - 1974 Clinical Instructor, Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1974 - 1977 Instructor, Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1977 - 1980 Assistant Professor, Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1980 - 1987 Associate Professor, Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1983 - 1990 Associate Professor, Medicine, Medical College of Wisconsin, Milwaukee, WI
1987 - 1990 Clinical Professor, Pediatrics, Medical College of Wisconsin, Milwaukee, WI
1990 - Present Professor, Pediatrics, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
1979 - 1984 Acting Section Head, Pediatrics, Immunology, Medical College of Wisconsin, Milwaukee, WI
1985 - 1995 Associate Director, Pediatrics, Bone Marrow Transplant Program, Medical College of Wisconsin, Milwaukee, WI
1997 - 2009 Division Chief, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
1983 - 1984 Director, Pediatrics, Bone Marrow Transplant Program, Children's Hospital of Wisconsin, Milwaukee, WI
1985 - 1997 Director, Pediatrics, Bone Marrow Transplant Program, Children's Hospital of Wisconsin, Milwaukee, WI
1987 - 1989 Chief, Medicine, Children's Hospital of Wisconsin, Milwaukee, WI
1989 - 1993 Vice Chief of Staff, Children's Hospital of Wisconsin, Milwaukee, WI

RESEARCH ADMINISTRATIVE APPOINTMENTS:
1972 - 1979 Assistant Medical Director, Blood Center of Southeastern Wisconsin, Milwaukee, WI
1979 - 1994 Associate Medical Director, Blood Center of Southeastern Wisconsin, Milwaukee, WI
1990 - 2011 Medical Director, Cell Marker Lab, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
1973 - Present Medical Staff, Children's Hospital of Wisconsin, Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
National Board of Medical Examiners
1971
None
American Board of Pediatrics
1975
None
American Board of Pediatric Hematology-Oncology
1976
None
 
Licensure
Number Issue DateExpiration
Wisconsin License
1971
None
 
AWARDS AND HONORS:
1992 - 2013 Elected by his peers for inclusion in Best Doctors in America
2013 - Present David A. Margolis Chair in Pediatric Bone Marrow Transplantation

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1980 - 1992 American Association of Immunologists
1981 - 1995 International Society for Experimental Hematology
1981 - 1990 American Association of Cancer Research
1981 - 2009 American Society for Clinical Oncology
1983 - Present American Society of Pediatric Hematology/Oncology
1988 - Present Clinical Immunology Society
1989 - 2007 Society for Biological Therapy
1992 - Present American Society for Hematology
1995 - Present American Society for Blood and Marrow Transplantation
1995 - 2009 European Society for Hematology
2010 - Present European Society for Immunodeficiencies

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
1982 - 1988 Investigational New Drugs: The Journal of New Anti-Cancer Agents
1999 - Present Pediatric Transplantation
Journal Review
1986 - Present Journal of Clinical Oncology
1988 - Present Blood
1990 - Present Bone Marrow Transplantation
1992 - Present American Journal of Pediatric Hematology-Oncology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1975 - 1985 Member, Medical Advisory Committee, Blood Center of Southeastern Wisconsin
1978 - 1980 Medical Advisor, Childhood Cancer Advisory Subcommittee, American Cancer Society Wisconsin Division
1979 - 1980 Milwaukee Children's Hospital Representative, Southeastern Wisconsin Perinatal System

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1981 - Present Pediatric Oncology Group
1985 Member, Program Committee, American Society of Clinical Oncology
1986 - 1994 Member, Neuroblastoma Core Committee, Pediatric Oncology Group
1986 - 1994 Member, Biologic Response Modifiers Committee, Pediatric Oncology Group
1986 - Present Member, Bone Marrow Transplant Core Committee - Pediatric
1988 - 1992 Chairperson, Biologic Response Modifiers Committee, Pediatric Oncology Group
1991 - 1997 Member, Membership Committee, National Donor Marrow Program
1993 - 1997 Member, Research and Publications Committee, National Marrow Donor Program
1993 - 1994 Member, Membership Committee Liaison to International Affairs Committee, National Marrow Donor Program
1993 - Present Medical Advisor, National Children's Cancer Society
1999 - 2000 Chairperson, Membership and Process Improvement Committee, National Marrow Donor Program
2010 - Present Member, PBMTC, Finance Committee

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Prior
Peer Review
Source:
American Cancer Society
Role:
Fellow
Dates:
7/1/1976 - 6/31/1979
Direct Funds:
$24,000
 
Title:
Immune Competent Cells in Acute Lymphocytic Leukemia
Source:
National Cancer Institute, RO1 CA18602
Role:
Co-Investigator
Dates:
1/1/1978 - 11/1/1979
Direct Funds:
$411,139
 
Title:
The Distribution and Functions of Lymphoid Cell Subpopulations in Acute Leukemia
Source:
American Cancer Society, IM-100E
Role:
Co-Investigator
Dates:
7/1/1978 - 12/31/1979
 
Title:
Childhood Neuroblastoma: Antigenic Characteristics
Source:
National Cancer Institute, RO1 CA26226
Role:
Co-Investigator
Dates:
7/1/1979 - 6/30/1982
Direct Funds:
$131,086
 
Title:
Immune Competent Cells in Acute Lymphocytic Leukemia
Source:
National Cancer Institute, RO1 CA18602
Role:
Appointed principal investigator following the death of Luis Borella
Dates:
11/1/1979 - 12/31/1982
Direct Funds:
$278,021
 
Title:
Pediatric Oncology Group Participation
Source:
National Cancer Institute, CA32053-10
Role:
Co-investigator
Dates:
1/1/1983 - 12/31/1985
 
Title:
Therapy Groups to Study T-cell Depletion in Unrelated Donor Marrow Transplantation
Source:
National Institutes of Health, NHLB1, N01 HB47097
Role:
Co-investigator
Dates:
11/1/1993 - 4/30/2001
Direct Funds:
$524,160
 
Non-Peer Review
Source:
Washington University, Pediatric Oncology Group Operations Office
Role:
Principal Investigator
PI:
James T. Casper
Dates:
1/6/1989 - 12/31/1990
Direct Funds:
$15,997
 
INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
1. Introduction and Practical Approaches to Bone Marrow Transplantation Today, ASHI Midwest Regional Educational Workshop, Milwaukee, WI, 1989
 
Regional
1. T-cell Depletion and the Control of GVHD in HLA Mismatched Bone Marrow Transplantation, American Society of Pediatric Hematology/Oncology, Chicago, IL, 1989
2. Bone Marrow Transplantation in the 90's, Wisconsin Association of Blood Banks, Appleton, WI, 1990
3. Bone Marrow Transplantation for the Pediatric Patient: The Unrelated Donor Experience, Children's Memorial Hospital, Chicago, IL, 1990
4. Biological Response Modifiers - A Standard of Therapy for the 90's? , Evening Conference The Challenge to Find a Bone Marrow Donor - Will Increased Donor Numbers Solve All of Our Problems, Cook-Fort Worth Children's Hospital, Fort Worth. TX, 1990
5. Medical Usefulness of Transplantation Chemistries from an Oncologist's Point of View, Kodak Ektachem Users' Seminar, University of Wisconsin Center for Health Sciences, Madison, WI, 1992
6. Unrelated BMT in the Pediatric Patient, University of Texas Southwestern Medical School, Dallas, TX, 1992
7. Mismatched Bone Marrow Transplantation for Children with Acute Lymphocytic Leukemia, American Society of Pediatric Hematology-Oncology, Chicago, IL, 1993
8. Bone Marrow Transplantation in the 90's, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 1995
 
National
1. Contract reviewer for Developmental Therapies - NCI - Application of a Human Tumor Colony Forming Assay to New Drug Screening, National Institute of Health, Bethesda, MD, 1984
2. Immune Functions and Cancer, Ad hoc member of site visit for Program Project, UCLA, 1986
3. Monoclonal Antibodies and Vaccines in Cancer Therapy, Ad hoc member of site visit for Program Project, Memorial Sloan Kettering Institute, 1988
4. Intravenous Immunoglobulin: Use in Pediatric Bone Marrow Transplantation, Immunoglobulin Symposium, Scottsdale, AZ, 1990
5. To T-Deplete or not to T-Deplete: Is There Still a Question?, Stanford Medical School, Palo Alto, CA, 1993
6. Aplastic Anemia, Education Session, American Society of Hematology, Orlando, FL, 1996
 
International
1. Inherited and Acquired Bone Marrow Failure, Co-Chair, European Society of Pediatric Hematology and Immunology Paris, France, 1989
2. Bone Marrow Transplantation for Severe Aplastic Anemia in Children, Aplastic Anemia Symposium, Toronto, Canada, 1990
 
COMMITTEE SERVICE:
Medical College
1983 - 1993 Member, Executive Committee, Pediatrics, Medical College of Wisconsin
1984 - 1990 Member, Pediatric House Staff Committee, Pediatrics, Medical College of Wisconsin
1984 - 1986 Member, Committee on Allocation of Equipment and Research Space, Pediatrics, Medical College of Wisconsin
1985 - Present Member, Radiation Therapy Search Committee, Medical College of Wisconsin
1988 - 1991 Member, Institutional Research Affairs Committee, Medical College of Wisconsin
1990 - Present Member, Cancer Center, Medical College of Wisconsin
1992 - Present Member, Five Year Review Committee Evaluating Radiation Therapy, Medical College of Wisconsin
1994 - 1996 Member, Clinical Practice Group (CPG) Board, Medical College of Wisconsin
1995 - Present Member, Medical Staff Funds Committee, Medical College of Wisconsin
 
Hospital
1981 - 1989 Member, Governing Staff, Milwaukee Children's Hospital
1984 - 1990 Member, Computer Committee, Milwaukee Children's Hospital
1985 - 1993 Member, Executive Committee, Children's Hospital of Wisconsin
1986 - 1987 Co-chairman, Competency Review Task Force, Children's Hospital of Wisconsin
1987 - 1993 Member, Planning Committee of the Board of Directors, Children's Hospital of Wisconsin
1987 - 1988 Member, Search Committee for Director of Pathology, Children's Hospital of Wisconsin
1987 - 1993 Member, Professional Affairs Committee of the Board of Directors, Children's Hospital of Wisconsin
1987 - 1990 Member, Competency Review Task Force, Children's Hospital of Wisconsin
1997 - 1999 Member, CVL Task Force, Children's Hospital of Wisconsin
 
MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
1977 - 2005 Pediatric Hematology/Oncology, Bone Marrow Transplant
1977 - 2005 Pediatric Ward Attending
1978 - 1992 Immunology, Hematology, Oncology Blood Banking Lectures
1979 - 1992 General Microbiology Seminar group 8 hours/year, General lecture 1 hour/year
Ward Attending
 

BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Lewis JD, Varma RR, Harrington G, Casper J, Ackmann JJ, Darin JC. Exchange transfusion for Reye's syndrome. J Surg Res. 1975 Mar;18(3):327-9.
2. Tang TT, Siegesmund KA, Sedmak GV, Casper JT, Varma RR, McCreadie SR. Reye syndrome. A correlated electron-microscopic, viral, and biochemical observation. JAMA. 1975 Jun 30;232(13):1339-46.
3. Casper JT, Varma RR, Lewis JD, Harrington GJ, Aster RH. Exchange transfusion in Reye's syndrome with saline-washed red blood cells. Transfusion. 1976 Mar-Apr;16(2):130-4.
4. Koethe SM, Casper JT, Rodey GE. Alternative complement pathway activity in sera from patients with sickle cell disease. Clin Exp Immunol. 1976 Jan;23(1):56-60.
5. Casper JT, Koethe S, Rodey GE, Thatcher LG. A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood. 1976 Feb;47(2):183-8.
6. Borella L, Sen L, Casper JT. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts. J Immunol. 1977 Jan;118(1):309-15.
7. Flomenberg P, Gutierrez E, Piaskowski V, Casper JT. Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction assay. J Med Virol. 1997 Mar;51(3):182-8.
8. Barr RE, Ackmann JJ, Harrington GJ, Varma RR, Lewis JD, Casper JT. Computerized evaluation of electroencephalographic changes accompanying exchange transfusion in Reye's syndrome. Electroencephalogr Clin Neurophysiol. 1977 Apr;42(4):466-79.
9. Borella L, Sen L, Dow LW, Casper JT. Cell differentiation antigens versus tumor-related antigens in childhood acute lymphoblastic leukemia (ALL). Clinical significance of leukemia markers. Haematol Blood Transfus. 1977;20:77-85.
10. Casper JT, Borella L, Sen L. Reactivity of human brain antiserum with neuroblastoma cells and nonreactivity with thymocytes and lymphoblasts. Cancer Res. 1977 Jun;37(6):1750-6.
11. Sheth KJ, Casper JT, Good TA. Interstitial nephritis due to phenytoin hypersensitivity. J Pediatr. 1977 Sep;91(3):438-41.
12. Lauer SJ, Casper JT, Borella L. The use of antibody-dependent cell mediated cytotoxicity (ADCC) assay to identify neuroblasts in human bone marrow. J Clin & Lab Immunol. 1978;1:77.
13. Lauer SJ, Casper JT, Borella LD. Immunodiagnosis of childhood ALL: problems associated with the use of peripheral blood alone. Med Pediatr Oncol. 1979;6(2):157-62.
14. Sty JR, Babbitt DP, Casper JT, Boedecker RA. 99mTc-methylene diphosphonate imaging in neural crest tumors. Clin Nucl Med. 1979 Jan;4(1):12-7.
15. Borella L, Casper JT, Lauer SJ. Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse. Blood. 1979 Jul;54(1):64-71.
16. Sty JR, Babbitt DP, Casper JT. Technetium methylene diphosphonate imaging in neural crest tumors. Clin Nucl Med. 1979;4:12.
17. Casper JT, Duquesnoy RJ, Borella L. Transient appearance of HLA-DRw-positive leukocytes in peripheral blood after cessation of antileukemia therapy. Transplant Proc. 1980 Mar;12(1):130-3.
18. Von Hoff DD, Casper J, Bradley E, Trent JM, Hodach A, Reichert C, Makuch R, Altman A. Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res. 1980 Oct;40(10):3591-7.
19. Sty JR, Casper JT, Oechler HW. Bone scintigraphy: retroperitoneal fibrosis. Wis Med J. 1980 Oct;79(10):27-8.
20. Sty JR, Kun LE, Casper JT. Bone scintigraphy in neuroblastoma with ovarian metastasis. Wis Med J. 1980 Sep;79(9):28-9.
21. Sty JR, Kun L, Casper J, Babbitt DP. Extraosseous uptake of 99mtechnetium methylene diphosphonate: neuroblastoma or radiation therapy. Pediatr Radiol. 1980;9(1):53-4.
22. Sty JR, Kun LE, Casper JT. Bone imaging as a diagnostic aid in evaluating neuroblastoma. Amer J of Ped Hematol/Oncol. 1980;2:115-118.
23. Camitta BM, Pinkel D, Thatcher LG, Casper J, Kun LE, Lauer S. Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia. Med Pediatr Oncol. 1980;8(4):383-9.
24. Kun LE, Casper JT, Kline RW, Piaskowski VD. Fractionated total body irradiation for metastatic neuroblastoma. Int J Radiat Oncol Biol Phys. 1981 Nov;7(11):1599-602.
25. Hayes FA, Green AA, Casper J, Cornet J, Evans WE. Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity. Cancer. 1981 Oct 15;48(8):1715-8.
26. Chusid MJ, Casper JT, Adair SE, Camitta BM. Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy. Wis Med J. 1981 Mar;80(3):32-3.
27. Von Hoff DD, Casper J, Bradley E, Sandbach J, Jones D, Makuch R. Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med. 1981 May;70(5):1027-41.
28. Casper JT, Marrari M, Piaskowski V, Lauer SJ, Duquesnoy RJ. Association between HLA-D region antigens and disease-free survival in childhood non-T, non-B acute lymphocytic leukemia. Blood. 1982 Sep;60(3):698-702.
29. Harris GJ, Zeagler J, Hodach A, Casper J, Harb J, Von Hoff DD. Ultrastructural analysis of colonies growing in a human tumor cloning system. Cancer. 1982 Aug 15;50(4):722-6.
30. Lauer S, Piaskowski V, Camitta B, Casper J. Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse. Leuk Res. 1982;6(6):769-74.
31. Von Hoff DD, Clark GM, Stogdill BJ, Sarosdy MF, O'Brien MT, Casper JT, Mattox DE, Page CP, Cruz AB, Sandbach JF. Prospective clinical trial of a human tumor cloning system. Cancer Res. 1983 Apr;43(4):1926-31.
32. Casper JT, Trent JM, Harb J, Piaskowski V, Helmsworth M, Finlan J, Von Hoff DD. Distinguishing characteristics of a new neuroblastoma cell line. Cancer Genet Cytogenet. 1983 Oct;10(2):177-86.
33. Sty JR, Starshak RJ, Casper JT. Extraosseous accumulation of Tc-99m MDP. Metastatic intracranial neuroblastoma. Clin Nucl Med. 1983 Jan;8(1):26-7.
34. Menitove JE, Aster RH, Casper JT, Lauer SJ, Gottschall JL, Williams JE, Gill JC, Wheeler DV, Piaskowski V, Kirchner P, Montgomery RR. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med. 1983 Jan 13;308(2):83-6.
35. Sty JR, Starshak RJ, Casper JT. Image correlation. Budd-Chiari Syndrome. Clin Nucl Med. 1983 Aug;8(8):369-70.
36. Lauer SJ, Finlan J, Borella LD, Piaskowski VD, Casper JT. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum. J Clin Lab Immunol. 1983 Oct;12(2):105-10.
37. Casper JT, Lauer SJ, Kirchner PA, Gottschall JL, Camitta BM. Evaluation of cerebrospinal fluid mononuclear cells obtained from children with acute lymphocytic leukemia: advantages of combining cytomorphology and terminal deoxynucleotidyl transferase. Am J Clin Pathol. 1983 Nov;80(5):666-70.
38. Kun LE, Camitta BM, Mulhern RK, Lauer SJ, Kline RW, Casper JT, Kamen BA, Kaplan BM, Barber SW. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation. J Clin Oncol. 1984 May;2(5):359-64.
39. Lauer SJ, Lyman S, Kirchner PA, Gottschall JL, Camitta BM, Casper JT. Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation. J Clin Lab Immunol. 1985 Jan;16(1):17-22.
40. Gill JC, Wheeler D, Menitove JE, Aster RH, Casper JT, Kirchner P, Montgomery RR. Persistence and progression of immunologic abnormalities in haemophilia. Thromb Haemost. 1985 Jun 24;53(3):328-31.
41. Harb JM, Piaskowski V, Casper JT. Contribution of electron microscopy of cell cultures to the classification of three round cell sarcomas in children. Ultrastruct Pathol. 1985;8(2-3):165-76.
42. Camitta BM, Lauer SJ, Casper JT, Kirchner PA, Kun LE, Oechler HW, Adair SE. Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children. Cancer. 1985 Aug 15;56(4):738-41.
43. Gill JC, Maples J, Nikaein A, Kirchner P, Lockhart D, Snyder AJ, Montgomery RR, Casper JT. Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous sickle cell disease. J Pediatr. 1985 Aug;107(2):251-3.
44. Trent J, Casper J, Meltzer P, Thompson F, Fogh J. Nonrandom chromosome alterations in rhabdomyosarcoma. Cancer Genet Cytogenet. 1985 Apr 1;16(3):189-97.
45. Tang TT, Harb JM, Dunne WM Jr, Wells RG, Meyer GA, Chusid MJ, Casper JT, Camitta BM. Cerebral toxoplasmosis in an immunocompromised host. A precise and rapid diagnosis by electron microscopy. Am J Clin Pathol. 1986 Jan;85(1):104-10.
46. Kamen BA, Casper J, Lauer S, Camitta BM, Holcenberg JS. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine. Cancer Treat Rep. 1986 Jul;70(7):935-6.
47. Camitta BM, Casper JT, Kun LE, Lauer SJ, Starshak RJ, Oechler HW. Isolated bilateral T-cell renal lymphoblastic lymphoma. Am J Pediatr Hematol Oncol. 1986;8(1):8-12.
48. Chusid MJ, Casper JT, Camitta BM, McCreadie SR. Cyclic neutropenia in identical twins. Am J Med. 1986 May;80(5):994-6.
49. Gill JC, Menitove JE, Anderson PR, Casper JT, Devare SG, Wood C, Adair S, Casey J, Scheffel C, Montgomery RR. HTLV-III serology in hemophilia: relationship with immunologic abnormalities. J Pediatr. 1986 Apr;108(4):511-6.
50. Merritt WD, Casper JT, Lauer SJ, Reaman GH. Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies. Cancer Res. 1987 Mar 15;47(6):1724-30.
51. Lauer SJ, Pinkel D, Buchanan GR, Sartain P, Cornet JM, Krance R, Borella LD, Casper JT, Kun LE, Hoffman RG. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia. Cancer. 1987 Nov 15;60(10):2366-71.
52. Brodeur GM, Hayes FA, Green AA, Casper JT, Wasson J, Wallach S, Seeger RC. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res. 1987 Aug 15;47(16):4248-53.
53. Piaskowski V, Nikaein A, Lauer S, Casper JT. The autologous mixed lymphocyte response: isolation of mononuclear cell populations by counterflow centrifugal elutriation. J Clin Lab Immunol. 1988 Jul;26(3):147-51.
54. Ash RC, Casper JT. Clinical cancer: 33. Clinical applications and research advances in marrow transplantation. Wis Med J. 1988 Nov;87(11):17-21.
55. Graham-Pole J, Camitta B, Casper J, Elfenbein G, Gross S, Herzig R, Koch P, Mahoney D, Marcus R, Munoz L. Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study. Bone Marrow Transpl. 1988 Nov;3(6):559-66.
56. Graham-Pole J, Gee AP, Gross S, Casper J, Graham M, Harvey W, Kapoor N, Koch P, Mendenhall N, Norris D. Bone marrow transplantation (BMT) for advanced neuroblastoma (NBL): a multicenter POG pilot study. Prog Clin Biol Res. 1988;271:215-23.
57. Bunin NJ, Casper JT, Chitambar C, Hunter J, Truitt R, Menitove J, Camitta BM, Ash R. Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. J Clin Oncol. 1988 Dec;6(12):1851-5.
58. Lawton CA, Barber-Derus S, Murray KJ, Casper JT, Ash RC, Gillin MT, Wilson JF. Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant. Int J Radiat Oncol Biol Phys. 1989 Aug;17(2):319-22.
59. Baxter-Lowe LA, Hunter JB, Casper JT, Gorski J. HLA gene amplification and hybridization analysis of polymorphism. HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome. J Clin Invest. 1989 Aug;84(2):613-8.
60. Camitta B, Leventhal B, Lauer S, Shuster JJ, Adair S, Casper J, Civin C, Graham M, Mahoney D, Munoz L. Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol. 1989 Oct;7(10):1539-44.
61. Camitta B, Ash R, Menitove J, Murray K, Lawton C, Hunter J, Casper J. Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. Blood. 1989 Oct;74(5):1852-7.
62. Longeway K, Mulhern R, Crisco J, Kun L, Lauer S, Casper J, Camitta B, Hoffman RG. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy. Am J Pediatr Hematol Oncol. 1990;12(1):45-50.
63. Casper JT, Ash RA, Kirchner P, Hunter JB, Havens PL, Chusid MJ. Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome"). J Pediatr. 1990 Feb;116(2):262-5.
64. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med. 1990 Feb 22;322(8):485-94.
65. Wyatt DT, Lum LG, Casper J, Hunter J, Camitta B. Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transpl. 1990 May;5(5):357-61.
66. Pole JG, Casper J, Elfenbein G, Gee A, Gross S, Janssen W, Koch P, Marcus R, Pick T, Shuster J. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991 Jan;9(1):152-8.
67. VanDevanter DR, Piaskowski VD, Casper JT, Douglass EC, Von Hoff DD. Ability of circular extrachromosomal DNA molecules to carry amplified MYCN proto-oncogenes in human neuroblastomas in vivo. J Natl Cancer Inst. 1990 Dec 5;82(23):1815-21.
68. Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. Transplantation. 1990 Oct;50(4):625-32.
69. Casper JT, Truitt RR, Baxter-Lowe LA, Ash RC. Bone marrow transplantation for severe aplastic anemia in children. Am J Pediatr Hematol Oncol. 1990;12(4):434-48.
70. LeFever AV, Piaskowski VD, Casper JT, Truitt RL. Kinetic analysis of human IL-2 activated cytotoxic cells. Immunopharmacol Immunotoxicol. 1991;13(1-2):147-68.
71. Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC, Henslee PJ, Kolb HJ, Lowenberg B, Masaoka T. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transpl. 1991 Jun;7(6):443-52.
72. Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Ash RC, Casper JT, Moulder JE. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer. 1991 Jun 1;67(11):2795-800.
73. Baxter-Lowe LA, Eckels DD, Ash R, Casper J, Hunter JB, Gorksi J. Future directions in selection of donors for bone marrow transplantation: role of oligonucleotide genotyping. Transplant Proc. 1991 Feb;23(1 Pt 2):1699-700.
74. Baxter-Lowe LA, Eckels DD, Ash R, Casper J, Hunter JB, Gorski J. The predictive value of HLA-DR oligotyping for MLC responses. Transplantation. 1992 Jun;53(6):1352-7.
75. Bunin NJ, Casper JT, Lawton C, Murray K, Camitta BM, Greenwood M, Geil J, Ash RC. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. Bone Marrow Transpl. 1992 Feb;9(2):119-22.
76. Werlin SL, Casper J, Antonson D, Calabro C. Pancreatitis associated with bone marrow transplantation in children. Bone Marrow Transpl. 1992 Jul;10(1):65-9.
77. Truitt RL, Piaskowski V, Kirchner P, McOlash L, Camitta BM, Casper JT. Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. J Immunother (1991). 1992 May;11(4):274-85.
78. Casper JT, Sedmak G, Harris RE, Carrigan DR, Baxter-Lowe LA, Ash RC. Intravenous immunoglobulin: use in pediatric bone marrow transplantation. Semin Hematol. 1992 Jul;29(3 Suppl 2):100-5.
79. Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, McAuliffe T, Camitta B, Horowitz MM, Bunin N. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis. 1994 Apr;169(4):775-81.
80. Lauer SJ, Camitta BM, Leventhal BG, Mahoney DH Jr, Shuster JJ, Adair S, Casper JT, Civin CI, Graham M, Kiefer G. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1993 May 1;71(9):2854-61.
81. Schad CR, Hanson CA, Paietta E, Casper J, Jalal SM, Dewald GW. Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia. Mayo Clin Proc. 1994 Nov;69(11):1047-53.
82. Johnson ST, McFarland JG, Kelly KJ, Casper JT, Gottschall JL. Transfusion support with RBCs from an Mk homozygote in a case of autoimmune hemolytic anemia following diphtheria-pertussis-tetanus vaccination. Transfusion. 2002 May;42(5):567-71.
83. Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood. 1994 Apr 1;83(7):1980-7.
84. Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood. 1995 May 1;85(9):2354-63.
85. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Characterization of human proliferative T cell responses to adenovirus. J Infect Dis. 1995 May;171(5):1090-6.
86. Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C, Garbrecht F. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplantation. 1995;16:271-5.
87. Drobyski WR, Casper JT, Horowitz MM, Keever-Taylor CA, Flombenberg N. Use of unrelated marrow grafts compensate for reduced graft-versus-leukemia reactivity after T-cell depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood. 1995;86:3987-96.
88. Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transpl. 1995 Aug;16(2):271-5.
89. Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood. 1995 Nov 15;86(10):3987-96.
90. Flomenberg P, Piaskowski V, Harb J, Segura A, Casper JT. Spontaneous, persistent infection of a B-cell lymphoma with adenovirus. J Med Virol. 1996 Mar;48(3):267-72.
91. Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J 3rd, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol. 1996 Jul;94(1):65-72.
92. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol. 1996 Sep;70(9):6314-22.
93. Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transpl. 1997 Jun;19(11):1069-77.
94. Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Bone Marrow Transpl. 1997 May;19(10):1001-9.
95. Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transpl. 1997 Dec;20(12):1069-74.
96. Link CJ Jr, Burt RK, Traynor AE, Drobyski WR, Seregina T, Levy JP, Gordon L, Rosen ST, Burns WH, Camitta B, Casper J, Horowitz M, Juckett M, Lawton C, Margolis D, Pietryga D, Rowlings P, Taylor C, Furtado M, Stefka J, Gupta-Burt S, Kaiser H, Vesole DH. Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. Hum Gene Ther. 1998 Jan 1;9(1):115-34.
97. Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski WR, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Bone Marrow Transpl. 1998 May;21(9):893-9.
98. Orentas RJ, Rospkopf SJ, Casper JT, Getts RC, Nilsen TW. Detection of Epstein-Barr virus EBER sequence in post-transplant lymphoma patients with DNA dendrimers. J Virol Methods. 1999 Feb;77(2):153-63.
99. Chen CL, Levine A, Rao A, O'Neill K, Messinger Y, Myers DE, Goldman F, Hurvitz C, Casper JT, Uckun FM. Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies. J Clin Pharmacol. 1999 Dec;39(12):1248-55.
100. Deeg HJ, Seidel K, Casper J, Anasetti C, Davies S, Gajeweski JL, Territo M, Ramsay N, Harris RE, Catro-Malaspina H, Collins R, Champlin R, Schoch G, King R, Howe C. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant. 1999;5(4):243-52.
101. Margolis DA, Casper JT. Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol. 2000 Jan;37(1):43-55.
102. Porter DL, Collins RH Jr, Hardy C, Kernan NA, Drobyski WR, Giralt S, Flowers ME, Casper J, Leahey A, Parker P, Mick R, Bate-Boyle B, King R, Antin JH. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood. 2000 Feb 15;95(4):1214-21.
103. Margolis DA, Casper JT, Segura AD, Janczak T, McOlash L, Fisher B, Miller K, Gorski J. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biol Blood Marrow Transplant. 2000;6(4):408-15.
104. Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT, Nademanee A, Noreen H, King R, Confer D, Kernan NA. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood. 2000 Dec 15;96(13):4096-102.
105. Porter DL, Collins RH Jr, Hardy C, Kernan NA, Drobyski WR, Giralt S, Flowers ME, Casper J, Leahey A, Parker P, Mick R, Bate-Boyle B, King R, Antin JH. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood. 2000 Feb 15;95(4):1214-21.
106. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant. 2001;7(11):620-30.
107. Drobyski WR, Morse HC 3rd, Burns WH, Casper JT, Sandford G. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene. Blood. 2001 Apr 15;97(8):2506-13.
108. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringdén O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001 Mar 15;97(6):1598-603.
109. Johnson ST, McFarland JG, Kelly KJ, Casper JT, Gottschall JL. Transfusion support with RBCs from an Mk homozygote in a case of autoimmune hemolytic anemia following diphtheria-pertussis-tetanus vaccination. Transfusion. 2002 May;42(5):567-71.
110. Bunin N, Carston M, Wall D, Adams R, Casper J, Kamani N, King R. National Marrow Donor Program Working Group. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood. 2002 May 1;99(9):3151-7.
111. Bin Q, Johnson BD, Schauer DW, Casper JT, Orentas RJ. Production of macrophage migration inhibitory factor by human and murine neuroblastoma. Tumour Biol. 2002 May-Jun;23(3):123-9.
112. Kupst MJ, Penati B, Debban B, Camitta B, Pietryga D, Margolis D, Murray K, Casper J Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study. Bone Marrow Transpl. 2002 Nov;30(9):609-17.
113. Orentas RJ, Schauer DW Jr, Ellis FW, Walczak J, Casper JT, Margolis DA Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients. Pediatr Transplant. 2003 Aug;7(4):305-14.
114. Abed N, Casper JT, Camitta BM, Margolis D, Trost B, Orentas R, Chang CC. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. Bone Marrow Transpl. 2004 Feb;33(3):321-7.
115. Pavletic SZ, Carter SL, Kernan NA, Henslee-Downey J, Mendizabal AM, Papadopoulos E, Gingrich R, Casper J, Yanovich S, Weisdorf D. National Heart, Lung, and Blood Institute Unrelated Donor Marrow Transplantation Trial Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood. 2005 Nov 1;106(9):3308-13.
116. Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. Bone Marrow Transpl. 2006 Jan;37(2):135-41.
117. Copelan E, Casper JT, Carter SL, van Burik JA, Hurd D, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA. A scheme for defining cause of death and its application in the T cell depletion trial. Biol Blood Marrow Transplant. 2007 Dec;13(12):1469-76.
118. Davies SM, Wang D, Wang T, Arora M, Ringden O, Anasetti C, Pavletic S, Casper J, Macmillan ML, Sanders J, Wall D, Kernan NA. Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants. Biol Blood Marrow Transplant. 2009 Mar;15(3):360-6.
119. Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, Serpe JM, Dasu T, Tschannen MR, Veith RL, Basehore MJ, Broeckel U, Tomita-Mitchell A, Arca MJ, Casper JT, Margolis DA, Bick DP, Hessner MJ, Routes JM, Verbsky JW, Jacob HJ, Dimmock DP. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011 Mar;13(3):255-62.
120. Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sánchez de Toledo J, Ferster A, Szabolcs P, Wingard JR, Horwitz E, Filipovich AH. Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2011 Dec;17(12):1783-9. doi: 10.1016/j.bbmt.2011.05.008. Epub 2011 May 20.
121. de Vries E, Alvarez Cardona A, Abdul Latiff AH, Badolato R, Brodszki N, Cant AJ, Carbone J, Casper JT, et al, European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012 Jan;167(1):108-19.
122. Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, Dasu T, Bonacci B, Reddy S, Margolis D, Casper J, Gries M, Desantes K, Hoffman GL, Brokopp CD, Seroogy CM, Routes JM. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011). J Clin Immunol. 2012 Feb;32(1):82-8. doi: 10.1007/s10875-011-9609-4. Epub 2011 Nov 10.
123. Miller EC, Chase NM, Densen P, Hintermeyer MK, Casper JT, Atkinson JP, . Autoantibody stabalization of the classical pathway C3 convertase leading to C3 deficiency and neisserial sepsis: C4 nephritic factor revisited. Clinical Immunology 2012 Dec;145(3):241-50. doi: 10.1016/j.clim.2012.09.007.Epub 2012 Sep 28
124. Marsh RA, Rao K, Satwani P, Lehmberg K, Muller I, Li D, Kim M, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper JT, Douglas DN, Amrolia PJ, Veys P, Kumar AR, Jordan MB, Bleesing JJ, Filipovich AH. Allogeneic hematopoietic cell transplantation for XIAP deficiency: An international survey reveals poor outcomes. Blood. 2013 Feb 7;121-(6):887-83
125. Chase, N, Verbsky, J.W., Hintermeyer, M., Casper, J., Singh, S., Shahir, S., Tisol, W.B., Rao, R.N., Mackinnon, A.C., Goodman, L., Simpson, P., Routes, J.M.: Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 2013 Jan;33(1):30-9
126. Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sánchez de Toledo J, Ferster A, Szabolcs P, Wingard JR, Horwitz E, Filipovich AH Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2011 Dec;17(12):1783-9
127. Oshima,K et al: Hematopoietic stem cell transplantation for X-linked thrombocytopenia with mutations in the WAS gene, J of Clinical Immunology, 2014 under review
 
Books, Chapters, and Reviews
1. Varma RR, Casper JT, Lewis JD, Harrington GJ. Changing patterns of reye's syndrome. In: Pollack JD, ed. Reye's syndrome. New York: Grune and Stratton; 1975:416-417.
2. Harrington GJ, Barr RE, Ackmann JE, Varma RR, Casper JT, Lewis JD. Electroencephalographic monitoring of exchange transfusion in Reye's syndrome. In: Pollack JD, ed. Reye's syndrome. New York: Grune and Stratton; 1975:61-64.
3. Borella L, Sen L, Dow LW, Casper JT. Cell differentiation antigens versus tumor-related antigens in childhood acute lymphoblastic leukemia (ALL). Clinical significance of leukemia markers. In: Thierfelder S, ed. Recent trends in immunological diagnosis of leukemias and lymphomas. New York: SpringerVerlag; 1977:77.
4. Borella L, Casper JT. Immunocompetence in childhood acute lymphocytic leukemia. In: Walters H, ed. The Handbook of Cancer and Immunology. New York: Garland Press; 1978:103.
5. Borella LD, Casper JT, Hodach A, Lauer SJ. A biological approach to the diagnosis of leukemias. In: Crowther DC, ed. Advances in medical oncology research and education. Vol 7. New York: Pergamon Press; 1979:7.
6. Casper JT, Pinkel D. Neuroblastoma. In: Gellis and Kagen, eds. Current Pediatric Therapy. Philadelphia, PA: Saunders and Co.; 1980:283.
7. Casper JT, Trent JM, Von Hoff DD. Cloning of human neuroblastoma cells in soft agar. Prog Clin Biol Res. 1980;48:101-11.
8. Casper JT, Trent JM, von Hoff D. Cloning of Human Neuroblastoma cells in soft agar. In: Salomon S, ed. Human Tumor Cloning. New York: Allen Liss and Co.;1980:101-111.
9. Jelsema CL, Merritt WD, Helmsworth M, Casper JT. Characterization of cells isolated from bone marrow and peripheral blood by elutriation. Methodological Survey (B) Biochemistry, Vol. 11, Cancer Cell Organelles, 1981.
10. Abrams RA, Casper J, Kun L, Kamen B, Hensen R, Camitta B, Anderson T. High-dose AZQ for patients with refractory CNS neoplasms - a preliminary analysis. In: KA Dicke, G Spitzer, AR Zanders. eds. Proceedings of International Symposium on Autologous Bone Marrow Transplantation. Houston, TX; M.D. Anderson Hospital; 1985:227-230.
11. Graham-Pole J, Gee AP, Gross S, Casper J, Graham M, Harvey W, Kapoor N, Koch P, Mendenhall N, Norris D, Pick T, Thomas P: Bone marrow transplantation (BMT) for advanced neuroblastoma (NBL): A multicenter POG pilot study. 4th International Symposium in Neuroblastoma Research, May, 1987.
12. Ash RC, Casper J, Serwint MS, Coffey C, Bruckman JE, Truitt R, Greenwood M, Geil J, Ramond E. Camitta B, McDonald J, Thompson J, Maruyama Y. Extending the application of allogeneic marrow transplantation for leukemic patients who lack matched sibling donors, utilizing partially matched donors in concert with T-cell depletion for GVHD prophylaxis. In: Gale RP and Champlin R, eds. Recent Advances in Bone Marrow Transplantation. New York: Alan R Liss, Inc.; 1987:365-79.
13. Casper JT, Bunin NB, Truitt R, Camitta B, Ash R. Pediatric bone marrow transplantation utilizing unrelated donors. In: Pochedly C, ed. Bone Marrow Transplantation in Children. 1989: 301-325.
14. Ash RC, Casper J, Menitove J, Chitambar C, Hansen R, Lum L, Lawton C, Murray K, Hunter J, Anderson T, Camitta B. Evolving role of the closely HLA-matched unrelated marrow donor: HLA matching considerations for alternative donor transplantation. In: Gale RP, Champlin R, eds. Bone Marrow Transplantation: Current Controversies. UCLA Symposia on Molecular and Cellular Biology, New Series. Vol 91. New York, NY: Alan R Liss, Inc.; 1989: 639-640.
15. Wexler L, Sondel P, Casper, J. Use of biological response modifiers and biologic therapy in pediatric oncology. In: Pochedly C, ed. Neoplastic Diseases of Childhood. Harwood Academic; 1994: 63-87.
16. Casper JT. Unrelated donor bone marrow transplantation for children with acute leukemia. Commentary. In: Stockman III, ed. Yearbook of Pediatrics. Ch 14. Mosby-Year Book; 1998: 448-450.
17. Orentas R, Casper JT. Immunotherapy in Pediatric Oncology. Immunology and Allergy Clinics of North America. 1999;19(2):309-326.
18. Margolis DA, Casper J. Allogeneic transplantation for acute myeloid leukemia in children. In: Forman SJ, Blum KG, Donnell Thomas E, ed. Hematopoietic cell transplantation. 2nd ed. Oxford: Blackwell Science Ltd.; 1999: Ch 71.
19. Margolis DA, Casper J. Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol. 2000 Jan;37(1):43-55.
20. Margolis D, Casper J. Allogeneic Transplantaiton for Acute Myeloid Leukemia in Children. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation, 3rd Edition. Oxford: Blackwell Science Ltd.; 2004: Ch 76.
21. Talano JM, Casper J, Margolis DA. Hematopoietic Cell Transplantation for Childhood Acute Myeloid Leukemia. In: Blum KG, Forman SJ, eds. Thomas' Hematopoietic Cell Transplantation, 4th edition. Oxford: Blackwell Science Ltd.; 2007: Ch 54.
 
Editorials, Letters to Editor, Other
1. Baselga E, Drolet BA, Casper J, Esterly NB. Chemotherapy associated supravenous hyperpigmentation. Dermatology. 1996;192:384-385.
2. Chusid MJ, Casper JT, Camitta BM Editors have ethical responsibilities, too. N Engl J Med. 1984 Oct 11;311(15):990-1
 
Abstracts
1. Lewis JD, Varma RR, Casper JT, Harrington GJ, Darin JC. Exchange transfusion in Reye's Syndrome. Gastroenterology Jr. 1974;67:809.
2. Casper JT, Rodey GE, Thatcher LG. A rapid simple method for evaluation of functional Asplenic in sickle cell disease. J Pediatr. 1974;84:909.
3. Casper JT, Koethe S, Rodey GE. Evidence for an alternate complement pathway defect other than C3 proactivator (C3PA) deficiency in sickle cell disease. J Clin Invest. 1974;53:14a.
4. Casper JT, Varma RJ, Lewis DJ, Harrington G, Aster RH. Treatment of Reye's syndrome with saline washed red blood cells. Transfusion. 1974;14:514.
5. Varma RR, Cherazil G, Casper JT, Lewis DJ, Harrington G, Parker HW. Fatty acids in Reye's syndrome. Dissimilarity to isovaleric and alphamethylbutyric acidemias. Clin Res. 1974;22:606.
6. Varma RR, Cherazil GT, Casper JT, Lewis JD, Harrington GJ, Parker HW. Short chain fatty acids in Reye's syndrome. Gastroenterology Jr. 1975;68:1086.
7. Casper JT, Pinkel D. Reactivity of fetal brain antisera with human neuroblastoma cells and thymocytes. P Am Assoc Canc Res. 1976;17:95.
8. Casper JT, Borella L, Pinkel D. Identification of tumor associated antigens by antineuroblastoma and TALL blast heterologous sera. P Am Assoc Canc Res. 1977;18:221.
9. Lauer SJ, Casper JT, Borella L. Inhibition by normal thymocytes of antibody-dependent cell-mediated cytotoxicity against tumor cells. P Am Assoc Canc Res. 1978;19:130.
10. Casper JT, Duquesnoy R, Borella LD. Surface antigens on ALL blasts and on normal lymphocytes after stopping chemotherapy. Proc Cong Int Soc Hematol. 1978;17:70.
11. Camitta B, Pinkel D, Thatcher LG, Casper J. Failure of early intensified therapy to improve prognosis in childhood acute lymphocytic leukemia. Blood. 1978;52:242a.
12. Casper JT, Duquesnoy R, Borella LD. HLA-DRW antigen(s) on peripheral blood cells after cessation of antileukemic therapy. P Am Assoc Canc Res. 1979;20:274(#1113).
13. Casper JT, Camitta BM, Hodach A, Altman A, Von Hoff DD. The soft-agar cloning technique for human neuroblastoma: potential for clinical studies. P Am Assoc Canc Res. 1980;21:168(#673).
14. Lauer S, Casper J, Camitta B. Heterogeneity in pediatric T-cell leukemia/lymphoma. P Am Assoc Canc Res. 1981;22:184(#729).
15. Lauer S, Casper J, Keller R, Kirchner P, Camitta B. The use of counter-flow centrifugation for separation of bone marrow lymphoid cells in children with ALL and metastatic solid tumors. Blood. 1981;58:84a.
16. Menitove JE, Gottschall JL, Aster RH, Casper JT, Lauer S, Wheeler D, Williams J, Gill J, Montgomery RR. Immunologic parameters of hemophiliac patients. Similarity to AIDS? Blood. 1982;6:218a(#799, Supp 1).
17. Lauer S, Casper J, Piaskowski V, Camitta B. Stability of membrane markers in childhood acute lymphoid neoplasias. P Am Assoc Canc Res. 1982;23:483a.
18. Casper JT, Piaskowski V, Wells J, Rosenblatt H, Seeger R. A monoclonal antibody cytotoxic to neuroblastoma (NBL) colony forming cells. P Am Assoc Canc Res. 1983;24:885.
19. Kun L, Camitta B, Mulhern R, Lauer S, Casper J, Kaplan B. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia (ALL): Results of craniospinal irradiation. Proc Am Soc Clin Oncol. 1983;2:78.
20. Green AA, Hayes FA, Casper J, Sartain P, Abildgaard C. Extended disease-free survival for patients with disseminated neuroblastoma treated with cyclophosphamide (cyclo), adriamycin (adria), cisplatin (DDP), and VM-26. P Am Assoc Canc Res. 1983;24:628a.
21. Abrams R, Polacek L, Hansen R, Casper J, Camitta B. Variable precryopreservation recovery of CFU-GM following Ficoll-Hypaque (FH) processing of autologous bone marrow collections (ABMC). Blood (American Society of Hematology Meeting Abstracts). 1983;62:768a.
22. Gill JC, Montgomery RR, Casper JT, Kirchner P, Wheeler D, Aster RH, Menitove JE. The incidence of new T-cell abnormalities in hemophilia. Blood (American Society of Hematology Meeting Abstracts). 1983;62:343a.
23. Abrams R, Polacek L, Casper J, Hansen R, Romain R, Kun L, Kamen B, Ritch P, Menitove J, Anderson T. Hematologically ablative therapy (Rx) supported by autologous hematopoietic reconstitution (AHR) at the Medical College of Wisconsin. The first 18 months. P Am Assoc Canc Res. 1984;3:104a.
24. Anderson T, Hansen R, Ritch P, Casper J, Hanson G, Abrams R, Grossberg S. Pilot trial of leukocyte HuIFN- (meloy Labs) interferon (-IFN) in chronic lymphocytic leukemia (CLL). Proc Am Soc Clin Oncol. 1984;3:764a.
25. Trent JM, Meltzer PS, Thompson FH, Casper JT, Fogh JE. Non-random chromosome alterations in rhabdomyosarcoma (RMS): possible association with a ras related oncogeny. P Am Assoc Canc Res. 1984;25:26Za.
26. Meltzer P, Casper J, Von Hoff D, Trent J. Application of recombinant DNA methodology for diagnosis of human neuroblastoma. Assessment of N-MYC amplification. Proc Am Soc Clin Oncol. 1985;4:933a.
27. Green AA, Casper J, Nitschke R, Smith EI, Hayes FA. The treatment of children with localized grossly unresectable (POG stage B) Neuroblastoma. Proc Am Soc Clin Oncol. 1985;4953a.
28. Brodeur G, Hayes A, Green A, Casper J, Lee H, Seeger R. Consistent N-MYC copy number in simultaneous or consecutive neuroblastoma samples from a given patient's tumor. Proc Am Soc Clin Oncol. 1986;5:13 (#52).
29. Gee AP, Graham-Pole J, Elfenbein G, Weiner R, Kemshead J, Pick T, Casper J, Marcus R, Nitschke R, Shuster J, Gross S. Disseminated (stage D) neuroblastoma (NBL): Engraftment and toxicity following autologous (auto) or allogeneic (allo) bone marrow transplantation (BMT). P Am Assoc Canc Res. 1986;27:202(#803).
30. Douglass EC, Wilimas JA, Sackey K, Casper J, Nitschke R. Efficacy of combination cisplatin (DDP) and VP-16 in the treatment of recurrent and advanced Wilms' Tumor (WT). Proc Am Soc Clin Oncol. 1986;5:201 (#789).
31. Ash RC, Casper J, Serwint MS, Coffey C, Bruckman JE, Greenwood M, Geil J, Romond E, Camitta B, McDonald J, Thompson J, Maruyama Y. Allogeneic marrow transplantation for leukemic patients who lack matched sibling donors, utilizing partially matched related donors in concert with T-cell depletion for GVHD prophylaxis. Proc Am Soc Clin Oncol. 1986;5:159(#620).
32. Graham-Pole J, Gross S, Camitta B, Casper J, Herzig R, Norris D, Koch P, Steuber P, Boyett J, Marcus R, Munoz L, Elfenbein G, Weiner R. Bone marrow transplantation (BMT) for acute lymphoblastic leukemia (ALL). Impact of conditioning with cytosine arabinoside (araC) and fractionated total body irradiation (fTBI) on subsequent relapse (rel): A Pediatric Oncology Group (POG) pilot. P Am Assoc Canc Res. 1986;27:206(#819).
33. Camitta B, Lauer S, Casper J, Adair S, Kamen B, Kun L. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphocytic leukemia (ALL). Proc Am Soc Clin Oncol. 1986;5:150(#585).
34. Bratanow NC, Ash RC, Turner PA, Smith R, Chitambar C, Hansen R, Casper J. Successful treatment of serious cytomegalovirus disease with 9 (1,3-dihydroxy-2propoxymethyl) guanine in bone marrow transplant (BMT) patients. Blood (American Society of Hematology Meeting Abstracts). 1986;68:999a.
35. Castleberry RP, Green AA, Casper J, Holbrook V, Mankad V, Etzl M. A pilot study of high dose cisplatinum (HDP) and high dose VP16 (HVP) in children with recurrent neuroblastoma (NB). Proc Am Soc Clin Oncol. 1987;6:857a.
36. Graham-Pole J, Casper J, Elfenbelin G, Gross S, Koch P, Krischer J, Munoz L, Norris D, Pick T, Spruce W, Steuber P. Bone marrow transplantation (BMT) for refractory acute lymphoblastic leukemia (ALL): A Pediatric Oncology Group (POG) study. Proc Am Soc Clin Oncol. 1987;6:581a.
37. Ash RC, Menitove J, Casper J, Chitambar C, Hansen R, Anderson T, Camitta B, Eckels D, Truitt R, Hunter J, Aster R. Unrelated donor marrow transplantation: Apparent benefits of T-depletion with post-transplant cyclosporin (CSA) for GVHD prophylaxis. Exp Hematol. 1987;15:592
38. Ash RC, Menitove J, Casper J, Chitambar C, Hansen R, Bratanow N, Lum L, Anderson T, Bunin N, Camitta B, Truitt R, Hunter J, Aster R. Successful allogeneic marrow transplantation utilizing HLA-closely matched unrelated donors. Blood. 1987;70:289a.
39. Bratanow N, Ash RC, Turner P, Smith R, Chitambar C, Hansen R, Casper J, Haasler G. The use of 9(1,3-dihydroxy-2-propoxymethyl) guanine (ganciclovir, DHPG) and intravenous immunoglobulin (IVIG) in the treatment of serious cytomegalovirus (CMV) infections in thirty-one allogeneic bone marrow transplant (BMT) patients. Blood (American Society of Hematology Meeting Abstracts). 1987;70:1065a.
40. Casper J, Bunin N, Hunter J, Murray K, Lum L, Truitt R, Menitove J, Aster R, Camitta B, Ash R. Unrelated bone marrow transplantation in children. J Cell Biochem. 1988;(Suppl 12c):97.
41. Camitta B, Casper JT, Hunter J, Bunin N, Menitove J, Lum L, Ash R. Alternative bone marrow donors for children with aplastic anemia. J Cell Biochem. 1988;(Suppl 12c):97.
42. Lauer S, Camitta B, Graham M, Leventhal B, Casper J, Civin C, Adair S. Early intensive rotating therapy for higher risk childhood acute lympho- cytic leukemia (CALL): A Pediatric Oncology Group (POG) pilot study. Proc Am Soc Clin Oncol. 1988;7:179.
43. Camitta B, Lauer S, Graham M, Leventhal B, Civin C, Casper J, Adair S. Early intensive methotrexate (MTX)/6 mercaptopurine (6MP) for lower risk childhood acute lymphocytic leukemia (ALL): A Pediatric Oncology Group (POG) pilot study. Proc Am Soc Clin Oncol. 1988;7:174.
44. Bunin NJ, Casper JT, Chitambar C, Hunter J, Truitt R, Menitove J, Camitta B, Ash R. Partially matched bone marrow transplantation (BMT) using T-cell depletion in patients with myelodysplastic syndromes (MDS). Proc Am Soc Clin Oncol. 1988;7:175.
45. Wyatt DT, Lum LG, Casper J, Hunter J, Camitta BM. Autoimmune thyroiditis after bone marrow transplant. Pediatr Res. 1988;23:350a.
46. Sheth KJ, Segura AD, Bunin NJ, Camitta BM, Ash RC, Casper JT. Renal involvement in partially matched bone marrow transplantation (BMT). Pediatr Res. 1988;23:546a.
47. Ash RC, Casper J, Menitove J, Chitambar C, Hansen R, Lum L, Anderson T, Camitta B, Truitt RT, Hunter J, Aster R. Successful allogeneic marrow transplantation utilizing HLA-closely matched unrelated donors. Blood. 1988;72:378a.
48. Casper J, Bunin N, Hunter J, Murray K, Lawton C, Menitove J, Lum L, Truitt R, Camitta B, Ash R. The successful use of unrelated donors for twenty-three pediatric bone marrow transplants. Blood. 1988;72:382a.
49. Graham-Pole J, Camitta B, Casper J, Elfenbein G, Gross S, Herzig R, Koch P, Mahoney D, Marcus R, Munoz L, Pick T, Spruce W, Steuber P, Weiner R. Marrow transplantation (BMT) for patients (PTS) with acute lymphoblastic leukemia (ALL): Reducing relapses and toxicity (TOX) post-BMT. Exp Hematol. 1988;16:345.
50. Graham-Pole J, Marcus R, Mendenhall N, Pick T, Thomas P, Koch P, Yeager A, Casper J, Spruce W, Luzins J, Elfenbein G, Gross S. Bone marrow transplantation (BMT) for patients (PTS) with metastatic neuroblastoma (NBL). Effects of prior remission (REM) status, use of total body (TBI) and Local (LI) irradiation. Proc Am Soc Clin Oncol. 1989;8:1156a.
51. Cohen EP, Sheth KJ, Hunter JB, Casper JT, Ash RC. Association of HLA-B40/12 and cross-reactive group with post-bone marrow transplant hemolytic uremic syndrome. American Society of Nephrology Abstracts, pg. 250a, 1989.
52. Casper J, Hunter J, Baxter-Lowe L, Murray K, Lawton C, Menitove J, Lum L, Truitt R, Camitta B, Ash R. The successful use of unrelated donors for fifty-five bone marrow transplants. Exp Hematol. 1989;17:499a.
53. Ash RC, Casper J, Lawton C, Hansen R, Chitambar C, Murray K, Camitta B, Anderson T, Truitt R. "Third generation" T depletion GVHD prophylaxis in genotypically HLA-matched sibling marrow transplantation: Durable engraftment with apparent preservation of the graft-versus¬leukemia (GVL) effect. Blood. 1989;74:122a.
54. Ash RC, Casper J, Hansen R, Chitambar C, Baxter-Lowe LA, Hunter J, Lawton C, Murray K, Truitt R, Camitta B, Anderson T, Menitove J. Successful marrow transplantation from closely HLA-matched unrelated donors. Blood. 1989;74:163a.
55. Camitta B, Casper JT, Hunter J, Menitove J, Ash R. Alternative bone marrow donors for children with aplastic anemia. J Cell Biochem. 1990;(Suppl 14a):283.
56. Casper J, Bunin N, Hunter J, Baxter-Lowe LA, Murray K, Lawton C, Menitove J, Truitt R, Camitta B, Ash R. Unrelated donors for pediatric bone marrow transplantation. J Cell Biochem. 1990;(Suppl 14a):326.
57. Casper J, Bunin N, Hunter J, Baxter-Lowe LA, Murray K, Lawton C, Truitt R, Camitta B, Ash R. Unrelated donors for bone marrow transplantation in children with leukemia. Proc Am Soc Clin Oncol. 1991;10:238.
58. Casper J, Baxter-Lowe LA, Truitt R, Murray K, Lawton C, Bunin N, Hunter J, Camitta B, Ash R. Unrelated donors for bone marrow transplantation in children. J Cell Biochem. 1992;(Suppl 16A):208.
59. Casper J, Camitta B, Ash R, Bunin N, Pietryga D, Garbrecht F, Baxter-Lowe LA, Murray K, Lawton C, Truitt R, Keever C, Flomenberg N. Bone marrow transplantation for Philadelphia chromosome positive (Ph+) acute lymphocytic leukemia (ALL) using alternative donors. Blood. 1992;80:65a.
60. Baxter-Lowe LA, Casper JT, Dinauer DM, Hoffman RG, Hessner MJ, Ash RC. Impact of HLA disparity in bone marrow transplantation utilizing unrelated donors. Blood (American Society of Hematology Meeting Abstracts). 1992 Nov 15;80(10 Suppl 1).
61. Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, Pietryga D, Hansen R, Chitambar C, Anderson T, Flomenberg N. Impact of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood. 1993;82:423a.
62. Casper J, Camitta B, Baxter-Lowe LA, Bunin N, Ash R, Pietryga D, Garbrecht F, Murray K, Lawton C, Truitt R, Keever C, Flomenberg N. Bone marrow transplantation (BMT) for childhood acute lymphocytic leukemia (ALL) using unrelated donors. Blood. 1993;82:170a.
63. Kawanishi Y, Flomenberg N, Gray A, Drobyski W, Horowitz M, Casper J, Camitta B, Pietryga D, Garbrecht F, Keever CA. Effect of T-cell subset content in acute graft vs. host disease following T-cell depleted bone marrow transplantation. Blood. 1993;82:423a.
64. Baxter-Lowe LA, Casper J, Flomenberg N, Dinauer D, Camitta B, Drobyski W, Garbrecht F, Pietryga D, Anderson T, Chitambar C, Hansen R, Lawton C, Bunin N, Keever C, Pierce K, Ash R. Impact of HLA disparity in bone marrow transplantation. J Immunol. 1993;150(8);part 2.
65. Camitta B, Casper J, Pietryga D, Garbrecht F, Ash R, Keever C, Murray K, Baxter-Lowe L, Flomenberg N. Unrelated donor bone marrow transplantation (BMT) for children with severe aplastic anemia. Blood. 1993;82:344a.
66. Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen E, Drobyski W, Horowitz M, Camitta B, Garbrecht F, Pietryga D, Lawton C, Ash R, Gottschall J. Therapeutic plasma exchange not effective in the management of TTP/HUS following bone marrow transplantation. Blood. 1993;82:419a.
67. Pietryga D, Camitta B, Casper J, Garbrecht F, Ash R, Bunin N, Keever C, Murray K, Baxter-Lowe LA, Flomenberg N. T-cell depleted bone marrow transplantation (BMT) for Wiskott-Aldrich syndrome (WAS) using unrelated donors. J Cell Biochem. 1994;(Suppl 18B):72.
68. Casper J, Camitta B, Baxter-Lowe LA, Bunin N, Ash R, Pietryga D, Garbrecht F, Murray K, Lawton C, Truitt R, Keever C, Flomenberg N. Bone marrow transplantation (BMT) for childhood acute lymphocytic leukemia (ALL) using unrelated donors. J Cell Biochem. 1994;(Suppl 18B):70.
69. Camitta B, Casper J, Pietryga D, Garbrecht F, Ash R, Keever C, Murray K, Baxter-Lowe LA, Flomenberg N. Bone marrow transplantation (BMT) for aplastic anemia (AA) using unrelated donors. J Cell Biochem. 1994;(Suppl 18B):69.
70. Pietryga D, Casper J, Garbrecht F, Camitta B, Drobyski W, Horowitz M, Lawton C, Keever C, Baxter-Lowe L, Murray K, Pierce K, Cadwallader S, McAuliffe T, Flomenberg N. Haploidentical bone marrow transplantation (BMT) for hematologic malignancies. Blood. 1994;84:339a.
71. Keever CA, Kawanishi Y, Wank T, Chaltry M, Craig A, Drobyski W, Horowitz M, Casper J, Camitta B, Pietryga D, Garbrecht F, Flomenberg N, Baxter-Lowe LA. Correlation of T-cell dose and CTL precursor frequency with graft versus host disease and survival after unrelated or partially matched related BMT. Blood. 1994;84:99a.
72. Howe C, Wagner J, Kernan N, Hurd D, Bishop M, Gingrich R, Kartzberg J, Casper J, Henslee-Downey J, Phillips G, Thomnson J, Domenberg A, Long G, Yanovich S and Carter-Campbell S. T-cell depletion in unrelated donor marrow transplantation. Blood (American Society of Hematology Meeting Abstracts). 1995 Nov 15;86(10 Suppl 1).
73. Pietryga D, Casper J, Margolis D, Camitta B, Garbrecht F, Drobyski W, Horowitz M, Burns W, Juckett M, Rowlings P, Passweg J, Lawton C, Taylor C, Baxter-Lowe L, Murray K, Pierce K, McAuliffe T, Flomenberg N. Bone marrow transplantation (BMT) using genotypically haploidentical donors. Blood (American Society of Hematology Meeting Abstracts). 1996 Nov 15;88(10 Suppl 1, 2 Pts).
74. Drobyski WR, Horowitz M, Pietryga D, Margolis D, Juckett M, Burns W, Camitta B, Rowlings P, Keever-Taylor C, Casper J. Unrelated donor marrow transplantation for acute myelogenous leukemia (AML), myelodysplasia, and secondary AML. Blood (American Society of Hematology Meeting Abstracts). 1996 Nov 15;88(10 Suppl 1, 2 Pts).
75. Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA. Association of host-reactive cytolytic and helper T cells with outcome following alternative donor T cell depleted bone marrow transplantation. Blood (American Society of Hematology Meeting Abstracts). 1996 Nov 15;88(10 Suppl 1, 2 Pts).
76. Kung FH, Bernstein ML, Casper JT, Goorin AM, Harris MB, Pratt CB. Low dose (yeast derived) GM-CSF in high dose ice therapy for the treatment of children with recurrent malignant solid tumors. Proc Am Soc Clin Oncol. 1997;16(#1885).
77. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb H-J, Lowenberg B, Masaoka T, Rowlings PA, Ondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang M-J, Horowitz MM. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997 May;15(5):1767-77.
78. Keever-Taylor CA, Rowlings P, Casper J, and Vesole D. CD34 dose but not CFU-GM, BFU-E or marrow dose correlates with platelet engraftment of T-cell depleted bone marrow. Blood (American Society of Hematology Meeting Abstracts). 1997;(90).
79. Porter D, Collins R, Mick R, Kernan N, Giralt S, Flowers M, Casper J, Drobyski W, Leahey A, Parker P, Bates B, King R, and Antin J. Unrelated donor leukocyte infusions (U-DLI) to treat relapse or EBV-Lymphoproliferative disease (EBV-LPD) after unrelated donor bone marrow transplantation (BMT), Blood (American Society of Hematology Meeting Abstracts). 1997;(90).
80. Davies SM, Harris RE, van Weel-Sitman MH, Dokal I, Skinner R, Casper JT, Kurtzberg J, Smith F, Karanes C, Chen A, Cairo M, Yeager A, and Wagner JE. Unrelated donor BMT for Fanconi anemia. Multicenter report of forty-nine cases, Blood (American Society of Hematology Meeting Abstracts). 1997;(90).
81. Baxter-Lowe LA, Parrish R, Margolis D, Szmania S, Seurynck K, White J, Wank T, Molter M, Hazlett L, Drobyski W, Garbrecht F, Pietryga D, Horowitz M, Camitta B, Vesole D, Burns W, Flomenberg N, Casper J, Keever-Taylor C. HLA disparity detected by automated nucleotide sequencing may aid in selection of alternative donors. Blood (American Society of Hematology Meeting Abstracts). 1997;(90):109a .
82. Margolis D, Pietryga D, Camitta B, Keever-Taylor C, Lawton C, Murray K, Garbrecht F, Casper J. Unrelated donor bone marrow transplantation for childhood AML: an update of the Milwaukee experience. Blood. 1997;90:397b.
83. Dinauer DM, Drobyski WR, Margolis DA, Casper JT, Keever CA, Hessner MJ. Development of a multi-resolution nested primer PCR assay for rapid detection and identification of fungi in human blood. Blood (American Society of Hematology Meeting Abstracts). 1998 Nov 15;92(10 Supp 1, 2 Pts).
84. Wagner JE, King R, Kollman C, Anasetti C, Antin J, Casper J, Champlin R, Davies SM, Drobyski W, Fay J, Filipovich A, Heslop H, Karanes C, Kernan N, Nademanee A, Schmeckpeper B, Howe C. Unrelated donor bone marrow transplantation (UBMT) in 5075 patients with malignant and non-malignant disorders. impact of marrow T cell depletion (TCD). Blood (American Society of Hematology Meeting Abstracts). 1998 Nov 15;92(10 Supp 1, 2 Pts).
85. Keever-Taylor C, Kabler-Babbitt C, Bauer D, Vesole D, Casper J, Burns W. The effect of growth factors, anti-thymocyte globulin, and CD34 cell dose on engraftment rate following T-cell depleted allogeneic BMT. Blood (American Society of Hematology Meeting Abstracts). 1999 Nov 15;94(10, 2 Pts).
86. Drobyski WR, Klein J., Pietryga D, Flomenberg N, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA, Bauer D, Burns WH, Casper JT. Superior Survival Associated with Transplantation of Matched Unrelated Versus Highly HLA-Disparate Haploidentical Family Marrow Grafts for the Treatment of Leukemia. Establishing a Treatment Algorithm for Recipients of Alternative Donor Grafts. Blood (American Society of Hematology Meeting Abstracts). 2000 Nov 16;96(11, 2 Pts).
87. Margolis DA, Dincer A, Anderson L, Moraski L, Casper J, Gottschall J. Serious Adverse Events in Parental Donors Undergoing Peripheral Blood Cell Mobilization: A trigger for Changing the Donation Process. Blood (American Society of Hematology Meeting Abstracts). 2001 Nov 16;98(11 Pt 1).
88. Talano JA, Margolis DA, Camitta BM, Keever-Taylor c, Murray K, Eapen M, Pierce K, Casper JT. Outcome of unrelated and haploidentical bone marrow transplants in children with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). Blood (American Society of Hematology Meeting Abstracts). 2002 Nov 16;100(11, 2 Pts).
89. Talano J, Keever-Taylor C, Eapen M, Casper J, Margolis DA. Haploidentical family donor transplants in children using high doses of positively selected CD34+ cells with low CD3+ cells. Blood (American Society of Hematology Meeting Abstracts). 2003 Nov 16;102(11, 2 Pts).
90. Margolis DA, Eapen M, Carreras J, Talano J, Browning M, Casper J. The role of race on survival after alternative donor hematopoietic progenitor cell transplant for pediatric acute leukemia. Provocative single center data. Blood (American Society of Hematology Meeting Abstracts). 2004 Nov 16;104(11 Pt 1):1a-1093a, (11 Pt 2):1b-416b.
91. Talano J, Camitta B, Keever-Taylor C, Anderson L, Wallach C, Casper J, Margolis DA. Long term outcomes of unrelated donor bone marrow transplantation in children with severe aplastic anemia. An update of the Milwaukee experience. Blood (American Society of Hematology Meeting Abstracts). 2006 Nov 16;108(11, 2 Pts).
92. Talano J, Brown J, Eastwood D, McArthur J, Casper J, Margolis D. Analysis of the incidence and characteristics of venoocclusive disease (VOD) of the liver in pediatric hematopoietic progenitor cell transplant (HPCT) patients with heparin alone vs. heparin and ursodiol prophylaxis at the medical college of wisconsin. Biol Blood Marrow Transplant. 2010;16(2):S248.
93. Dasu T, Sigua J, Bauer C, Casper J, Routes J and Verbsky J. Abstract and poster: Perforin Deficiency in an Adolescent with Inflammatory Bowel Disease. Association of Medical Laboratory Immunologists. August 2012.
94. Bauer C, Dasu T, Sigua J, Routes J, Verbsky J. Oral abstract: Perforin Deficiency in a Child with Severe Colitis. Clinical Immunology Society (CIS) Advanced Primary Immunodeficiency (PID) School. May 2012.
95. Bauer C, Dasu T, Sigua J, Casper J, Routes J, Verbsky J. Abstract: Severe Colitis in a Child with Perforin Deficiency. J Clin Immunol. Volume 32(2): 361-362. April 2012.
96. "Perforin Deficiency in an Adolescent with Inflammatory Bowel Disease" Trivikram Dasu, Jerome A. Sigua, Cindy Bauer, James Casper, John Routes, James Verbsky. The Association of Medical Laboratory Immunologists, Annual Meeting, Abstract and Poster Presentation. Minneapolis, MN.
97. "Severe Colitis in a Child with Perforin Deficiency" Cindy S. Bauer, Trivikram Dasu, Jerome A. Sigua, James T. Casper, John M. Routes, and James W. Verbsky. Primary Immune Deficiency Diseases North American Conference; Clinical Immunology Society, Abstract. Chicago, IL